Experience | News | Products | Other
This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Microalbuminuria
Microalbuminuria is defined as excretion of between 30 and 300 mg of albumin a day in the urine.
- Less than 30 mg is insignificant.
- Over 300 mg is albuminuria or macroalbuminuria.
Albumin levels below 300 mg a day are not detectable by standard protein dipstick testing, so any positive result is more severe than "microalbuminuria".
Patients with type 2 diabetes may have microalbuminuria at presentation as they may have had latent disease for years.
This is not usual in type 1 diabetes. Hence it is recommended that annual screening for microalbuminuria should start at diagnosis in type 2 but only after 5 years in type 1.1
Risk factors
Diabetes and hypertension are both risk factors but together the risk is very high.
Other causes of albuminuria include:
- Glomerulonephritis
- Amyloidosis
- Other forms of nephropathy
All pass through a brief phase of microalbuminuria, but this is short and the diagnosis is usually made with a more substantial proteinuria.
- An early morning urine specimen should be sent for albumin:creatinine ratio (more convenient than a 24 hours collection).2The upper limit of normal is regarded as a urine albumin:creatinine ratio of:
- 2.5 mg/mmol in men
- 3.5 mg/mmol in women
- A positive result should be repeated once or twice in the next month and if it is borderline a full 24 hours urine collection will give a more definitive result.
- Levels below 300 mg a day are not detectable by conventional dipstick testing but there are now some sticks for microalbuminuria available on the market.
- False positive results can occur after heavy exercise or with UTI.
- If a diabetic develops heavy proteinuria, especially in a fairly short space of time, then another cause should be sought.
- The same is true if there is no retinopathy.
- If eGFR falls below 60 mL/min/1.73 m2 referral to a nephrologist is recommended.3
The three pillars of management are:
|
NICE advises ACE inhibitors (or angiotensin II receptor antagonists) should be offered to all who:2
- Have CKD and hypertension with an ACR of 30 mg/mmol or more, or
- Have CKD and hypertension with urinary excretion of 0.5 g/24 hours or more
| In type 1 diabetes microalbuminuria is a prognostic indicator of renal failure, but in type 2 diabetes it is a prognostic indicator of ischaemic heart disease. |
Microalbuminuria is a powerful predictor of increased mortality.8
The process can be reversed by controlling blood pressure, especially with ACE inhibitors. Glycaemic control is not quite so vital. Stopping smoking is imperative.
Intensive management of blood pressure and glycaemia in both type 1 and type 2 diabetes has been shown in the DCCT and UKPDS to improve outcome.9
For the best outcome for heart and kidneys a combination of blood pressure control, use of ACE inhibitors, statins and aspirin are required.10
Document references
- Diabetes - type 2 (update), NICE Clinical Guideline (May 2008); Type 2 diabetes: the management of type 2 diabetes (update)
- Chronic kidney disease, NICE Clinical Guideline (September 2008); Early identification and management of chronic kidney disease in adults in primary and secondary care
- The Renal Association; UK Guidelines for the management of Chronic Kidney Disease. June 2005.
- Wade VL, Gleason BL; Dual blockade of the renin-angiotensin system in diabetic nephropathy. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1278-82. Epub 2004 Jun 8. [abstract]
- Chuahirun T, Simoni J, Hudson C, et al; Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci. 2004 Feb;327(2):57-67. [abstract]
- Sleight P; The HOPE Study (Heart Outcomes Prevention Evaluation). J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. [abstract]
- Dykeman-Sharpe J; Proteinuria, a modifiable risk factor: angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs).; CANNT J. 2003 Oct-Dec;13(4):34-6; quiz 37-8. [abstract]
- Allen KV, Walker JD; Microalbuminuria and mortality in long-duration type 1 diabetes. Diabetes Care. 2003 Aug;26(8):2389-91. [abstract]
- No authors listed; Intensive diabetes management: implications of the DCCT and UKPDS. Diabetes Educ. 2002 Sep-Oct;28(5):735-40.
- Deferrari G, Ravera M, Berruti V, et al; Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S6-S11. [abstract]
Internet and further reading
- NSF for Diabetes
DocID: 365
Document Version: 21
DocRef: bgp2115
Last Updated: 21 Jan 2009
Review Date: 21 Jan 2011
The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest.
Find out more about updating.
Advert
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicinePatient UK Newspaper (^ top of page)
Latest Health News
View current health newsRelated Products (^ top of page)
Medical equipment

Books

Other - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window





